A large gap in our understanding of infant immunity is why natural killer (NK) cell responses are deficient, which makes infants more prone to viral infection. Here we demonstrate that transforming growth factor-b (TGF-b) was responsible for NK cell immaturity during infancy. We found more fully mature NK cells in CD11c dnR mice, whose NK cells lack TGF-b receptor (TGF-bR) signaling. Ontogenic maturation of NK cells progressed faster in the absence of TGF-b signaling, which results in the formation of a mature NK cell pool early in life. As a consequence, infant CD11c dnR mice efficiently controlled viral infections. These data thus demonstrate an unprecedented role for TGF-b in ontogeny that can explain why NK cell responses are deficient early in life.
A r t i c l e s
The ability of NK cells to respond rapidly without prior sensitization places them at the front line of defense against infection 1 . This attribute largely depends on their ability to sense and kill virusinfected cells 2 . Detection of virus-infected cells is ensured by a repertoire of germ line-encoded receptors specialized in the recognition of stress-induced ligands as well as decreased abundance of major histocompatibility complex (MHC) class I molecules 3 . Once in contact with infected cells, NK cells rapidly secrete granzymes and perforins to control viral spread within hours of infection 4, 5 .
The program of such rapid cytotoxicity requires that NK cells are armed with pre-existing stocks of mRNA encoding granzymes and perforins. Results of prior studies suggest that this program is initiated during the development of NK cells and that pre-arming of NK cells is completed at the terminal step of maturation 6, 7 . In that regard, NK cells have a unique developmental pathway when compared to other cytotoxic lymphocytes.
Development of NK cells requires three major steps: commitment to the NK cell lineage, establishment of NK cell education and maturation of NK cells 8 . The first step is commonly identified by the acquisition of interleukin 2 receptor β (IL-2Rβ, stage A) on the precursor NK (pNK) cells 9 , although an earlier progenitor that lacks IL-2Rβ has been recently identified before the pNK stage 10 . The next step requires upregulation of NK1.1 and delineates the immature stage 11 . At this stage, immature NK (iNK) cells initiate expression of MHC class I recognition receptors encoded by Ly49 genes (also known as Klra genes). Two stages of iNK cells are distinguished based on differing expression of inhibitory and activating Ly49 receptors (stage B-C) 12 . Subsequently, NK cells upregulate CD49b (DX5) and enter the maturation process 11 . NK cells develop into mature NK (mNK) cells in three stages based on progressive expression of CD11b and CD43: stage D (CD11b − CD43 − ), the least mature; stage E (CD11b + CD43 − ), intermediate; and stage F (CD11b + CD43 + ), terminally mature. The molecular events that drive maturation of NK cells have been extensively studied, which has revealed several positive regulators, including IL-15Rα 13 , T-bet 14 , GATA-3 (ref. 15 ), IRF-2 (ref. 16 ), MEF 17 , MITF 18 and CEBP-γ 19 . Although in the NK cell field, great advances have been made in deciphering the mechanisms driving maturation of NK cells, a remaining major issue is unresolved: why NK cells do not complete maturation early in life.
Immaturity of NK cells in neonates and infants is an underlying factor for increased susceptibility to infection early in life [20] [21] [22] . Most reports converge to show that NK cell responses are strongly lower in neonates and infants compared to adults, as indicated by fewer cytoplasmic granules, poor degranulation ability and impaired release of lytic factors 23, 24 . Moreover, the ability of transferred adult NK cells to protect neonate mice from murine cytomegalovirus (MCMV) infection provides clear evidence of impaired NK cell function early in life 25 . Collectively, the current assumptions support the notion that immaturity of NK cells during early life is the result of intrinsic deficiency [20] [21] [22] [23] [24] . Instead, we found that this defect is orchestrated by an extrinsic factor TGF-β. We obtained direct evidence that TGF-β was the factor responsible for NK cell immaturity during ontogeny and for increased susceptibility to infection during mouse infancy. We demonstrate that NK cells could complete maturation early in life if TGF-βR signaling was blocked, which indicates plasticity of the maturation of NK cells during ontogeny. To improve infants' responses to infection, it is therefore tempting to propose the functional inactivation of TGF-βR signaling as a strategy to reverse the deficit in NK cells. 8 4 4 VOLUME 13 NUMBER 9 SEPTEMBER 2012 nature immunology A r t i c l e s RESULTS TGF-b controls the production of NK cells One major consequence from the lack of TGF-βR signaling in innate cells (CD11c dnR mice, which are transgenic mice expressing a dominant negative form of TGF-β receptor type II under the control of the promoter of CD11c 26 ) was the generation of a larger pool of mature NK cells in the periphery 26 . Specifically, mature NK cells from spleen, blood and liver have been found to be 5-10 times more abundant in CD11c dnR mice compared to control littermates 26 . Our finding that TGF-β limits NK cell number raised a central question: is TGF-βR Figure 1 TGF-β is a negative regulator of NK cell generation. (a) Flow cytometry of cultured bone marrow cells (gated on CD3 − cells) at different durations of culture. CD11c dnR and wild-type (WT) mice injected intraperitoneally with 5-fluorouracil. Four days later, mice were killed and hematopoietic stem cell (HSC)-enriched bone marrow cells were cultured in the presence of IL-7, SCF and Flt3L. On day 5, cells were collected, plated on OP9 stromal cells and cultured in the presence of IL-15. On day 8, cultures were supplemented with or without TGF-β, and outcomes of the production of mature NK cells were determined on day 11. Numbers indicate frequency of hematopoietic stem cells (c-kit + Sca-1 + ), NK cell precursors (CD122 + NKG2D + ), immature (NK1.1 + CD122 + ) and mature (NK1.1 + DX5 + ) NK cells on day 3, 5, 8, and 11, respectively. (b) Numbers of mature NK cells (CD3 − NK1.1 + DX5 + ) from CD11c dnR and wild-type (WT) cultures produced on day 11 in the absence versus the presence of TGF-β. Data are representative of two experiments with n = 3 mice per experiment (a,b; mean ± s.e.m. in b). A r t i c l e s signaling required at a precursor stage (production) or at a mature level (homeostasis)? To address this question, we used a hematopoietic stem cell culture approach and directly assessed the effect of TGF-β on production of NK cells ( Fig. 1) . Production of NK cells from multipotent stem cells can be recapitulated in vitro through two steps of differentiation 27 . In the first step (days 0-5), we cultured bone marrow-enriched multipotent stem cells (Lin − Sca-1 + c-kit + ) in the presence of fms-like tyrosine kinase 3 ligand (Flt3L), stem cell factor (SCF) and interleukin-7 (IL-7) to generate the first committed NK cell progenitors (CD122 + NKG2D + ). In the second step (days 5-11), we drove NK cell progenitors to differentiate into immature (CD122 + NK1.1 + ) and mature (NK1.1 + DX5 + ) NK cells under the influence of IL-15 and OP9 stromal cells. To determine the role of TGF-β during production of NK cells, we treated cultures with TGF-β on day 8 and assessed outcomes on day 11 ( Fig. 1) . We found that addition of TGF-β severely blocked the derivation of mature NK cells from wild-type precursors as demonstrated by 95-98% decrease in the number of NK1.1 + DX5 + cells compared to that in untreated cultures ( Fig. 1) . This finding provides the first line of evidence that TGF-β limits NK cell number at a precursor stage.
TGF-b controls terminal step of the maturation of NK cells
If TGF-β limits NK cell number at a precursor stage, then at what stage does the control by TGF-β occur? To identify such a putative stage, we analyzed the development of TGF-β-resistant NK cells in vivo using CD11c dnR mice (Fig. 2) . Based on the current map of NK cell development 8 , we examined four stages including the hematopoietic stem cells, the earliest NK cell precursors (pNK cells), iNK cells and mNK cells. We describe phenotype identification at each stage in Supplementary Figure 1 . We quantified the numbers of each cell subset, but found no major changes for hematopoietic stem cells, pNK cells or iNK cells between CD11c dnR and wild-type mice ( Fig. 2a) . In contrast, analysis of the mNK cell compartment revealed increased numbers of mature NK cells at the terminal differentiation stage in the bone marrow of CD11c dnR mice when compared to wild-type littermates ( Fig. 2b-f ). Distribution of CD11b versus CD43 among wild-type mNK cells showed a majority of cells at stages D and E, but we detected fewer mNK cells at stage F. In contrast, mNK cells that developed in the absence of TGF-βR signaling were found predominantly at stage F ( Fig. 2b-f ). This finding was demonstrated by augmented frequency of CD11b + CD43 + mNK cells in the bone marrow of CD11c dnR mice ( Fig. 2b) . Such increases translated into a tenfold gain in numbers of terminally mature NK cells produced in the absence of TGF-βR signaling ( Fig. 2c) . Enhanced maturation of TGF-β-resistant NK cells as identified by upregulation of CD43 was confirmed by the loss of CD27, another marker commonly used to identify terminally mature NK cells 28 (Fig. 2d,e and Supplementary Fig. 2 ). To ascertain this finding, we analyzed in parallel the BALB/c strain and confirmed higher production of terminally mature NK cells in the absence of TGF-βR signaling (Supplementary Fig. 3 ). To extend this finding, we examined the relationship between numbers of CD11b + CD43 + mNK cells produced in the bone marrow versus numbers established in the spleen (Fig. 2f ). As predicted, we observed proportional increases in the spleen, indicating that increased NK cell numbers in the spleen of CD11c dnR mice were the result of augmented production of NK cells from the bone marrow. Notably, all CD11b + CD43 + mNK cells from CD11c dnR mice expressed NKp46 (ref. 29 ), indicating that these cells were bona fide terminally mature NK cells ( Supplementary Fig. 4 ). Collectively, these data demonstrate that TGF-βR signaling is a checkpoint at the terminal step of the maturation of NK cells and a determining factor in the production of NK cells from the bone marrow.
TGF-b-resistant mNK cells dominate in cellular competition
To ascertain whether augmented maturation of NK cells in CD11c dnR mice is cell-autonomous, we re-examined the development of TGF-βresistant NK cells in mixed bone marrow chimeras ( Fig. 3) . In the npg A r t i c l e s first experiments, we constructed mixed bone marrow chimeras using a 1:1 ratio of wild-type (CD45.2 + ) and CD11c dnR (CD45.1 + ) donor cells, and compared the development of NK cells from both sources in the same environment ( Fig. 3a,b ). We found that development of NK cells from CD11c dnR origin resulted in abundant mNK cells at stage F (Fig. 3b) , a phenotype reminiscent of increased production of NK cells in CD11c dnR mice (Fig. 2b) . In direct comparison, the development of NK cells from wild-type donor cells resulted in much fewer mNK cells at stage F (Fig. 3b) , consistent with normal production of NK cells in wild-type mice (Fig. 2b) .
Notably, NK cells arising in the bone marrow were proportionally established in the periphery, as demonstrated by dominance of TGF-β-resistant NK cells over controls despite equal chimerism ( Supplementary Fig. 5a ).
In the second experiments, we constructed mixed bone marrow chimeras with dominant fractions of wild-type donor cells and asked whether TGF-β-resistant mNK cells can over-ride under these limiting conditions ( Fig. 3c-e ). To this aim, we constructed mixed bone marrow chimeras with wild-type (CD45.2 + ) and CD11c dnR (CD45.1 + ) donor cells provided in the inoculum at 1:1, 2:1, 4:1 and 9:1 ratios ( Fig. 3c) . Six weeks after transfer, we examined cellular chimerism along NK cell development as illustrated in Supplementary Figure  5b . As expected, bone marrow inoculum proportionally established chimerism in pNK and iNK cell compartments, reflecting dominance of wild-type origin (Fig. 3e) . However, as developing NK cells progressed through maturation, cellular chimerism gradually reversed, culminating in the dominance of TGF-β-resistant mNK cells at stage F (Fig. 3d,e) .
Two major points emerged from these experiments. First, normal numbers of wild-type CD11b + CD43 + mNK cells arising from 1:1 bone marrow ratios in the mixed chimeras showed that augmented production from CD11c dnR origin was cell-intrinsic, not microenvironmentdependent. Second, the dominance of transgenic CD11b + CD43 + mNK cells in 9:1 ratios of wild-type to CD11c dnR bone marrow chimeras demonstrated that production of mature NK cells in the bone marrow is superior in the absence of TGF-β.
Signals downstream TGF-b limit maturation of NK cells
To determine how TGF-β controls production of NK cells, we first examined their proliferation upon maturation (Fig. 4) . It has been shown that substantial proliferation occurs in developing NK cells while they are still immature. However, additional proliferation wanes in mature NK cells 11 . Based on this model, we hypothesized that TGF-β limits production of NK cells via cell-cycle arrest at terminal maturation. Consistent with previous studies, we found that 5-bromodeoxyuridine (BrdU) staining in wild-type mice severely declined during the transition from iNK to mNK cell stage (Fig. 4a,c) . In contrast, TGF-β-resistant NK cells exhibited enhanced proliferation upon maturation, resulting in maximum cell numbers at the mNK cell stage (Fig. 4a,c) . To determine which population accounted for the increased proliferation of TGF-β-resistant mNK cells, we examined the distribution of BrdU staining at stages D, E and F (Fig. 4b,d) . Unexpectedly, we found increased proliferation of stage D and E TGF-β-resistant mNK cells, rather than proliferation of stage F cells (Fig. 4b,d) .
Next, to identify target genes, we used a cell cycle-specific array and examined changes associated with lack of TGF-βR signaling along the maturation of NK cells (Fig. 4e) . Among 25 cell cycle-related genes, two genes-Cdc7 and p21 (Cdkn1a)-emerged as candidates associated with increased proliferation of TGF-β-resistant mNK cells at stages D and E. Increased proliferation at stage D was associated with upregulation of Cdc7 (a protein kinase essential for initiation of DNA replication) 30 , whereas robust proliferation at stage E correlated with downregulation of p21 (an inhibitor of cell-cycle progression to the G1 stage) 31 . Notably, we observed no changes at stage F, confirming results above (Fig. 4d) . npg A r t i c l e s Because substantial proliferation occurred at stage E, but cells accumulated at stage F, we reasoned that transition of NK cells from stage E to stage F must be facilitated in the absence of TGF-βR signaling. To test this hypothesis, we examined the expression of T-bet, GATA-3 and IRF-2, three transcription factors known to govern transition of NK cells to terminal maturation [14] [15] [16] (Fig. 4f) . Compared to control cells, TGFβ-resistant mNK cells showed an eight-to tenfold increase in the abundance of mRNA encoding T-bet and GATA-3 at stage F. Notably, we observed no substantial changes at stages D and E, indicating a selective role of TGF-β in limiting expression of T-bet and GATA-3 upon terminal maturation of NK cells. To confirm this finding, we treated mature NK cells with exogenous TGF-β, and determined expression of mRNA encoding T-bet and GATA-3 by quantitative reversetranscription (RT)-PCR ( Supplementary Fig. 6 ). Similar to the case in T cells 32 , we found that TGF-β was a potent suppressor of T-bet and GATA-3 expression in NK cells. Based on these data, we conclude that TGF-β limits production of NK cells by arresting NK cell cycle at stages D and E via Cdc7 and p21 and by limiting transition of NK cells to stage F via T-bet and GATA-3.
Efficient maturation of NK cells in CD11c dnR infants
Immaturity of the immune system, including incomplete maturation of NK cells, is one major limitation of early life in both humans and mice 33, 34 . In this context, our finding that TGF-β limits maturation of NK cells raised a key question: is TGF-βR signaling responsible for immaturity of NK cells during ontogeny? To address this question, we examined maturation of NK cells during ontogeny and determined outcomes of a lack of TGF-βR signaling at three stages of NK cell life 35, 36 : neonatal (0-10 d), infant (17-25 d) and adult (≥56 d) ( Fig. 5) .
We found that acquisition of maturation of NK cells during ontogeny occurred differently in CD11c dnR mice, as maturation of mNK cells progressed faster in the absence of TGF-βR signaling (Fig. 5a,b) . Specifically, numbers of CD11b + CD43 + mNK cells as a function of age revealed substantial maturation in CD11c dnR pups as early as 10 d of age. At this age, wild-type NK cells did not terminally mature, as demonstrated by the lack of CD11b + CD43 + mNK cells at both neonatal and infant mouse stages (Fig. 5b,c) . As expected, we detected terminally mature NK cells in adult wild-type mice, but the amount of these cells produced at 56 d of age was equivalent to that obtained from CD11c dnR mice at 10 d of age (Fig. 5b,c) . Analysis of the spleen provided another demonstration that ontogenic maturation of NK cells progressed faster in the absence of TGF-βR signaling (Fig. 5b,c) . At 10 d of age, none of wild-type mNK cells completed terminal maturation, whereas 25% of TGF-β-resistant mNK cells were at stage F. At 20 d of age, only a few stage F mNK cells emerged in wild-type spleen, whereas 50% of mNK cells in CD11c dnR mice already terminally matured. At 56 d of age, optimum terminal maturation was reached in both mouse groups, but tenfold more cells recovered from CD11c dnR versus wild-type spleens.
To better characterize the ontogenic maturation of TGF-β-resistant NK cells, we examined infant CD11c dnR mice for early acquisition of NK cell receptors (Fig. 6) . As the acquisition of NK cell receptors precedes maturation of NK cells 37 , we asked whether TGF-β has a role in the acquisition of NK cell receptors at early age. Regardless of their age, we found that mNK cells exhibited similar NK cell receptor expression in CD11c dnR versus wild-type mice, indicating that early acquisition of NK cell receptors was not controlled by TGF-βR signaling (Fig. 6a,b and Supplementary Fig. 7a) . However, the segregation of NK cell receptors on the basis of CD43 marker was a powerful tool to conclusively demonstrate early maturation of NK cells in infant CD11c dnR mice (Fig. 6a,c and Supplementary Fig. 7b) . These data provide direct evidence that TGF-β is responsible for NK cell immaturity during ontogeny.
Protection of CD11c dnR infants from MCMV infection
Consistent with faster maturation of TGF-β-resistant NK cells (Fig. 7a,b) , we found that infant CD11c dnR mice were resistant to 
npg
A r t i c l e s MCMV infection, whereas wild-type littermates succumbed to infection as expected (Fig. 7c) . Susceptibility of infant wild-type mice was demonstrated by high viral titers (Fig. 7c) as well as severe lymphopenia (Supplementary Fig. 8) . In contrast, infection of infant CD11c dnR mice resulted in strong reduction of viral titers, indicating efficient control of MCMV infection (Fig. 7c) . Control of MCMV infection in adult mice has been shown to be dependent on robust proliferation of Ly49H + NK cell subset 11, [38] [39] [40] . Thus, we asked whether protection from MCMV infection in infant CD11c dnR mice was associated with proliferation of Ly49H + NK cells. In this case, we treated MCMV-infected infant mice with BrdU and determined the frequency of cycling cells among Ly49H − versus Ly49H + NK cell subsets (Fig. 7d,e ). Ly49H + NK cells from infant CD11c dnR mice exhibited robust proliferation, consistent with resistance to MCMV npg infection (Fig. 7e) . In contrast, Ly49H + NK cells from infant wild-type littermates did not proliferate in response to MCMV, consistent with NK cell immaturity and viral susceptibility during infancy.
DISCUSSION
One major gap in the current map of NK cell development is that signals that limit the generation of NK cells remain unknown. The process of generating NK cells is tightly controlled and results from a balance between extracellular signals that cooperate with optimal amounts of transcription factors 8 . These factors can be divided in two groups based on the current map of the development of NK cells: IL-2Rγ, PU.1 and Id2 are required for commitment to the NK cell lineage, whereas IL-15Rα, T-bet, GATA-3 and IRF-2 promote maturation of NK cells. Here we showed that TGF-β negatively regulates maturation of NK cells. What signals limit production of NK cells at stage F? The distribution of NK cells in the bone marrow revealed that most mNK cells were identified at stages D and E but fewer were detected at stage F. Based on this, we postulated that mechanisms of negative regulation must operate at the transition to terminal maturation. This study provided several lines of evidence supporting this hypothesis. First, lack of TGF-βR signaling in CD11c dnR mice uncovered massive production of terminally mature NK cells as identified by upregulation of CD43 (ref. 11) and loss of CD27 (ref. 28) . Second, parallel analysis of CD11c dnR mice on BALB/c background confirmed that development of NK cells in the absence of TGF-βR signaling results in high production at terminal maturation. Third, outcomes of cellular competition in mixed bone marrow chimeras conclusively demonstrated that augmented production of stage F mNK cells from CD11c dnR origin is cell-autonomous. These data provide evidence that TGF-β imposes constraints at the terminal step of maturation of NK cells as a means of controlling production of NK cells from the bone marrow.
We found that control by TGF-β occurs at two levels upon maturation of NK cells. The first checkpoint is to prevent cell-cycle progression as developing NK cells mature. Results from CD11c dnR mice revealed high rates of proliferation as TGF-β-resistant NK cells matured, but this massive proliferation was associated with stages D and E rather than stage F. In an attempt to define the molecular mechanism, we referred to previous studies of TGF-β cytostatic function 41, 42 . Based on these studies, we identified a set of TGF-β response genes that can promote cell-cycle arrest upon NK cell maturation: at the core of this set are the activation of p21 and the inhibition of Cdc7. The notion that proliferation of developing NK cells wanes upon maturation has been reported previously 11 . The point of particular interest here is the demonstration that TGF-β is the signal that promotes cell-cycle arrest as developing NK cells mature.
The observation that transition to stage F correlates with high amounts of T-bet and GATA-3 in CD11c dnR mice identifies the second checkpoint by TGF-β. Transition to terminal maturation depends on three transcription factors, namely T-bet 14 , GATA-3 (ref. 15 ) and IRF-2 (ref. 16) . Accumulated data from studies of mutant mice show that NK cells deficient in T-bet, GATA-3 or IRF-2 have the same abnormality, as demonstrated by a blockade at CD11b lo CD43 lo stage (stage D-E) associated with functional defects 8, [14] [15] [16] . By comparison, we found that development of NK cells in the absence of TGF-βR signaling results in massive production at CD11b + CD43 + stage (stage F), and this gain correlated with high expression of T-bet and GATA-3. Our data support a model in which T-bet and GATA-3 promote transition of NK cells to terminal maturation, whereas TGF-β imposes constraints on both transcription factors to control outcomes of the production of NK cells from the bone marrow. This model is supported by the observation showing that (i) TGF-β is a potent suppressor of T-bet and GATA-3 in T cells 32 , (ii) TGF-β can efficiently suppress T-bet and GATA-3 in NK cells and (iii) ectopic expression of high amounts of T-bet in precursor cells correlates with augmented production of mature NK cells 14 . The role of T-bet and GATA-3 in NK cells triggered extensive interest because, unlike T cells, NK cells express and require both transcription factors to complete maturation. Here we showed that outcomes of terminal maturation result from the interplay between TGF-β and transcription factors T-bet and GATA-3. Such an instructive role of TGF-β upstream of T-bet and GATA-3 identifies a new signaling axis in determining the fate of maturation of NK cells.
Still, the scope of this study is the demonstration that deficient maturation of NK cells during infancy is the result of TGF-β signal. Analysis of the maturation of NK cells during ontogeny provided clear evidence that NK cells do not complete maturation in early life. To our surprise, we discovered that NK cells can complete maturation as early as 10 d of age if TGF-βR signaling is blocked. As a result, CD11c dnR mice featured mature NK cell compartment at early age, whereas the formation of a pool of mature NK cells in wild-type mice was delayed until adult age. One important consequence of this phenotype was efficient control of viral infection in CD11c dnR infant mice. MCMV-infected CD11c dnR infant mice showed substantial reduction of MCMV titers and robust proliferation of Ly49H + NK cells, a cell subset that specifically recognizes the m157 glycoprotein encoded by MCMV 11, [38] [39] [40] . In contrast, Ly49H + NK cells from wild-type pups did not proliferate in response to MCMV infection, although Ly49H + NK cells from wild-type adult mice are capable of efficient proliferation 11 . Nevertheless, earlier work has provided evidence that proliferation of NK cells from adult mice can be suppressed by TGF-β in response to lymphocytic choriomeningitis virus infection 43, 44 . In agreement with our finding, most reports converge to show that NK cell functions are strongly diminished in early life 23, 24 . In this context, our data demonstrate an unprecedented role for TGF-β in ontogeny that explains why NK cell responses are deficient early in life.
We do not know the exact source of TGF-β during ontogeny, but one mechanism could arise from the high activity of regulatory T cells (T reg ) in early childhood 45, 46 . Indeed, increased activity of T reg cells in early life is undisputable as it is demonstrated by high numbers of T reg cells as well as potent immunosuppressive activity in the cord blood 45, 46 . Such an immunosuppressive environment would be critical in preventing deleterious inflammation in early life. The consequence, however, is immaturity of NK cells and increased susceptibility to infection. Thus, our study contributes to the evolution of the current model of NK cell development by adding TGF-β as a critical determinant of maturation of NK cells during ontogeny.
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